CNTX – context therapeutics inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

CNTX

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

10/2

08:39 am

cntx

Rating for CNTX

Low Report

Rating for CNTX

Report

10/2

08:02 am

cntx

Context Therapeutics (NASDAQ:CNTX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.

Medium Report

Context Therapeutics (NASDAQ:CNTX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.

Report

10/2

06:44 am

cntx

Context Therapeutics initiated with an Overweight at Cantor Fitzgerald

Medium Report

Context Therapeutics initiated with an Overweight at Cantor Fitzgerald

Report

10/2

06:04 am

cntx

Context Therapeutics initiated with an Overweight at Cantor Fitzgerald

Medium Report

Context Therapeutics initiated with an Overweight at Cantor Fitzgerald

Report

9/18

09:14 am

cntx

Context Therapeutics (NASDAQ:CNTX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $5.00 price target on the stock.

High Report

Context Therapeutics (NASDAQ:CNTX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $5.00 price target on the stock.

Report

9/18

09:14 am

cntx

Context Therapeutics (NASDAQ:CNTX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $5.00 price target on the stock.

High Report

Context Therapeutics (NASDAQ:CNTX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $5.00 price target on the stock.

Report

9/18

09:01 am

cntx

Rating for CNTX

Medium Report

Rating for CNTX

Report

9/18

09:01 am

cntx

Rating for CNTX

Medium Report

Rating for CNTX

Report

9/17

04:39 pm

cntx